Resultados de procura - Akira Nishimura

Limitar resultados
  1. 1
    Transformation of<i>Aspergillus</i>sp. and<i>Trichoderma reesei</i>Using the Pyrithiamine Resistance Gene (<i>ptrA</i>) of<i>Aspergillus oryzae</i>

    Transformation of<i>Aspergillus</i>sp. and<i>Trichoderma reesei</i>Using the Pyrithiamine Resistance Gene (<i>ptrA</i>) of<i>Aspergillus oryzae</i> por Takafumi Kubodera, Nobuo Yamashita, Akira Nishimura

    Publicado 2002
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  2. 2
    Pyrithiamine Resistance Gene (<i>ptrA</i>) of<i>Aspergillus oryzae</i>: Cloning, Characterization and Application as a Dominant Selectable Marker for Transformation

    Pyrithiamine Resistance Gene (<i>ptrA</i>) of<i>Aspergillus oryzae</i>: Cloning, Characterization and Application as a Dominant Selectable Marker for Transformation por Takafumi Kubodera, Nobuo Yamashita, Akira Nishimura

    Publicado 2000
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  3. 3
    Randomized, double‐blind, placebo‐controlled study to assess the efficacy and safety of vortioxetine in Japanese patients with major depressive disorder

    Randomized, double‐blind, placebo‐controlled study to assess the efficacy and safety of vortioxetine in Japanese patients with major depressive disorder por Takeshi Inoue, Kiyofumi Sasai, T Kitagawa, Akira Nishimura, Isao Inada

    Publicado 2019
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  4. 4
    Unilateral choroidal excavation in the macula detected by spectral‐domain optical coherence tomography

    Unilateral choroidal excavation in the macula detected by spectral‐domain optical coherence tomography por Yuka Wakabayashi, Akira Nishimura, Tomomi Higashide, Shigeyuki Ijiri, Kazuhisa Sugiyama

    Publicado 2010
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  5. 5
    Randomized, double‐blind, placebo‐controlled 8‐week trial of the efficacy, safety, and tolerability of 5, 10, and 20 mg/day vortioxetine in adults with major depressive disorder

    Randomized, double‐blind, placebo‐controlled 8‐week trial of the efficacy, safety, and tolerability of 5, 10, and 20 mg/day vortioxetine in adults with major depressive disorder... por Akira Nishimura, Yutaka Aritomi, Kiyofumi Sasai, T Kitagawa, Atul R. Mahableshwarkar

    Publicado 2017
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  6. 6
    Roles of Mg<sup>2+</sup> in TPP‐dependent riboswitch

    Roles of Mg<sup>2+</sup> in TPP‐dependent riboswitch por Takahiro Yamauchi, Daisuke Miyoshi, Takafumi Kubodera, Akira Nishimura, Susumu Nakai, Naoki Sugimoto

    Publicado 2005
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  7. 7
    Nitric Oxide-Mediated Antioxidative Mechanism in Yeast through the Activation of the Transcription Factor Mac1

    Nitric Oxide-Mediated Antioxidative Mechanism in Yeast through the Activation of the Transcription Factor Mac1 por Ryo Nasuno, Miho Aitoku, Yuki Manago, Akira Nishimura, Yu Sasano, Hiroshi Takagi

    Publicado 2014
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  8. 8
    Vonoprazan, a novel potassium-competitive acid blocker, as a component of first-line and second-line triple therapy for<i>Helicobacter pylori</i>eradication: a phase III, randomised, double-blind study

    Vonoprazan, a novel potassium-competitive acid blocker, as a component of first-line and second-line triple therapy for<i>Helicobacter pylori</i>eradication: a phase III, randomise... por Kazunari Murakami, Yuuichi Sakurai, Madoka Shiino, Nobuo Funao, Akira Nishimura, Masahiro Asaka

    Publicado 2016
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  9. 9
    Redox Signaling Regulated by Cysteine Persulfide and Protein Polysulfidation

    Redox Signaling Regulated by Cysteine Persulfide and Protein Polysulfidation por Shingo Kasamatsu, Akira Nishimura, Masanobu Morita, Tetsuro Matsunaga, Hisyam Abdul Hamid, Takaaki Akaike

    Publicado 2016
    Ligazón do recurso Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  10. 10
    Acid‐inhibitory effects of vonoprazan 20 mg compared with esomeprazole 20 mg or rabeprazole 10 mg in healthy adult male subjects ‐ a randomised open‐label cross‐over study

    Acid‐inhibitory effects of vonoprazan 20 mg compared with esomeprazole 20 mg or rabeprazole 10 mg in healthy adult male subjects ‐ a randomised open‐label cross‐over study por Yuichi Sakurai, Yujiro Mori, Hiroyuki Okamoto, Akira Nishimura, Emiko Komura, Tsuyoshi Araki, Masanari Shiramoto

    Publicado 2015
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  11. 11
    Plasticity and injury in the developing brain

    Plasticity and injury in the developing brain por Michael V. Johnston, Akira Ishida, Wako Nakajima Ishida, Hiroko Matsushita, Akira Nishimura, Masahiro Tsuji

    Publicado 2008
    Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  12. 12
    Effect of Bread Containing Resistant Starch on Postprandial Blood Glucose Levels in Humans

    Effect of Bread Containing Resistant Starch on Postprandial Blood Glucose Levels in Humans por Yuji Yamada, Seio Hosoya, Shigeru Nishimura, Takashi Tanaka, Yoshitaka Kajimoto, Akira Nishimura, Osami Kajimoto

    Publicado 2005
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  13. 13
    Randomised clinical trial: a dose‐ranging study of vonoprazan, a novel potassium‐competitive acid blocker, vs. lansoprazole for the treatment of erosive oesophagitis

    Randomised clinical trial: a dose‐ranging study of vonoprazan, a novel potassium‐competitive acid blocker, vs. lansoprazole for the treatment of erosive oesophagitis por Kiyoshi Ashida, Yuichi Sakurai, Akira Nishimura, Kentarou Kudou, Naoki Hiramatsu, Eiji Umegaki, Katsuhiko Iwakiri, T. Chiba

    Publicado 2015
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  14. 14
    Thiamine‐regulated gene expression of <i>Aspergillus oryzae thiA</i> requires splicing of the intron containing a riboswitch‐like domain in the 5′‐UTR

    Thiamine‐regulated gene expression of <i>Aspergillus oryzae thiA</i> requires splicing of the intron containing a riboswitch‐like domain in the 5′‐UTR por Takafumi Kubodera, Mutsumi Watanabe, Kumi Yoshiuchi, Nobuo Yamashita, Akira Nishimura, Susumu Nakai, Katsuya Gomi, Hideo Hanamoto

    Publicado 2003
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  15. 15
    Randomised clinical trial: vonoprazan, a novel potassium‐competitive acid blocker, vs. lansoprazole for the healing of erosive oesophagitis

    Randomised clinical trial: vonoprazan, a novel potassium‐competitive acid blocker, vs. lansoprazole for the healing of erosive oesophagitis por Kiyoshi Ashida, Yuichi Sakurai, Tetsuharu Hori, Kentarou Kudou, Akira Nishimura, Naoki Hiramatsu, Eiji Umegaki, Katsuhiko Iwakiri

    Publicado 2015
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  16. 16
    Vonoprazan prevents ulcer recurrence during long-term NSAID therapy: randomised, lansoprazole-controlled non-inferiority and single-blind extension study

    Vonoprazan prevents ulcer recurrence during long-term NSAID therapy: randomised, lansoprazole-controlled non-inferiority and single-blind extension study por Yuji Mizokami, Kazunori Oda, Nobuo Funao, Akira Nishimura, Satoshi Soen, Takashi Kawai, Kiyoshi Ashida, Kentaro Sugano

    Publicado 2017
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  17. 17
    Vonoprazan prevents low-dose aspirin-associated ulcer recurrence: randomised phase 3 study

    Vonoprazan prevents low-dose aspirin-associated ulcer recurrence: randomised phase 3 study por Takashi Kawai, Kazunori Oda, Nobuo Funao, Akira Nishimura, Yasushi Matsumoto, Yuji Mizokami, Kiyoshi Ashida, Kentaro Sugano

    Publicado 2017
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  18. 18
    Maintenance for healed erosive esophagitis: Phase III comparison of vonoprazan with lansoprazole

    Maintenance for healed erosive esophagitis: Phase III comparison of vonoprazan with lansoprazole por Kiyoshi Ashida, Katsuhiko Iwakiri, Naoki Hiramatsu, Yuuichi Sakurai, Tetsuharu Hori, Kentarou Kudou, Akira Nishimura, Eiji Umegaki

    Publicado 2018
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  19. 19
    Randomised clinical trial: efficacy and safety of vonoprazan vs. lansoprazole in patients with gastric or duodenal ulcers – results from two phase 3, non‐inferiority randomised controlled trials

    Randomised clinical trial: efficacy and safety of vonoprazan vs. lansoprazole in patients with gastric or duodenal ulcers – results from two phase 3, non‐inferiority randomised con... por Hiroto Miwa, Noriya Uedo, Jiro Watari, Yujiro Mori, Yuichi Sakurai, Yohei Takanami, Akira Nishimura, T Tatsumi, Nobuhiro Sakaki

    Publicado 2016
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  20. 20
    Evaluation of the Efficacy and Safety of Vonoprazan in Patients with Nonerosive Gastroesophageal Reflux Disease: A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study

    Evaluation of the Efficacy and Safety of Vonoprazan in Patients with Nonerosive Gastroesophageal Reflux Disease: A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicen... por Yoshikazu Kinoshita, Yuuichi Sakurai, Madoka Shiino, Kentarou Kudou, Akira Nishimura, Takuya Miyagi, Katsuhiko Iwakiri, Eiji Umegaki, Kiyoshi Ashida

    Publicado 2016
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:

Ferramentas de procura: